Drugs / KXV01 TCR Lentinvivo Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07207681 | Oct 2025 → Dec 2026 expected | cancer | The First Hospital of Jilin University | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KXV01 TCR Lentinvivo Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07207681 ↗ |